Henstillingerne vedrørende fremstilling af talgbaserede stoffer til brug i farmaceutiske præparater (CPMP/ BWP/ 1163/ 97 - vedtaget i december 1997), samt henstillingerne vedrørende anvendelse af gelatine i farmaceutiske præparater blev medtaget i den foreslåede revision af CPMP´s guideline vedrørende TSE.
The recommendations (adopted in December 1997) for the production of tallow derivatives for use in pharmaceuticals (CPMP/ BWP/ 1163/ 97), as well as the recommendations for gelatine use in pharmaceuticals, were incorporated into the proposed revision of the ‘ TSE guideline’.